Blocking protein may prevent blinding disease

Sep 16, 2009
Dr. Wenbo Zhang, a senior postdoctoral fellow in the MCG Vascular Biology Center, is dissecting the relationship of interleukin-6 and one of the complications, diabetic retinopathy, and recently received a three-year, $270,000 advanced postdoctoral fellowship from the Juvenile Diabetes Research Foundation International to see if blocking this pro-inflammatory protein can target a new treatment for the potentially blinding disease. Credit: Medical College of Georgia

Blocking a protein that battles infection may help thwart a common cause of vision loss in chronic diseases such as diabetes, Medical College of Georgia researchers say.

The protein, , prompts inflammation - a healthy and sometimes lifesaving defense against invaders such as bacteria and viruses. But the protein's action "is bad in diseases like diabetes because the inflammation is chronic," says Dr. Wenbo Zhang, a senior postdoctoral fellow in the MCG Vascular Biology Center.

The key insult in diabetes is excess glucose, which causes inflammation and unleashes a cascade of complications. Dr. Zhang is dissecting the relationship of interleukin-6 and one of the complications, , and recently received a three-year, $270,000 advanced postdoctoral fellowship from the Juvenile Diabetes Research Foundation International to see if blocking this pro-inflammatory protein can target a new treatment for the potentially blinding disease.

"Diabetic retinopathy is the leading cause of blindness in working-age adults, so if we can find something to prevent it, slow it down or even cure it, that would be a good thing," says Dr. Zhang, who working with Dr. Ruth Caldwell, a cell biologist in the MCG Vascular Biology Center and Charlie Norwood Veterans Affairs Medical Center.

Dr. Zhang will determine whether increased levels of interleukin-6 in the vitreous, a gel-like substance in the center of the eye, will prompt small in the retina to leak. Fluid then collects in the retina, causing swelling and blurred vision. Unchecked, this can lead to proliferation of new blood vessels, which further obstruct vision.

"Blocking interleukin-6 may stop the small blood vessels from leaking," Dr. Zhang says. "Interleukin-6 receptor neutralizing antibody could be a new therapeutic approach for treating diabetic retinopathy. It is already in clinical trial for the treatment of rheumatoid arthritis and may provide a possible immediate benefit for diabetic retinopathy patients."

Says Dr. Caldwell, "If you can control the blood glucose levels, you can reduce the risk of diabetic retinopathy. Ideally, you would try to control the levels perfectly, but this is nearly impossible to achieve so other therapies are needed, and this would be one of them."

Source: Medical College of Georgia

Explore further: Breakthrough points to new drugs from nature

add to favorites email to friend print save as pdf

Related Stories

Natural compound stops retinopathy

Jul 02, 2009

Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. The research appears online ...

Researchers create first model for retina receptors

Sep 30, 2008

A team of scientists at the University of Oklahoma Health Sciences Center has created the first genetic research model for a microscopic part of the eye that when missing causes blindness. The research appears in a recent ...

Recommended for you

Breakthrough points to new drugs from nature

Apr 16, 2014

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

World's first successful visualisation of key coenzyme

Apr 16, 2014

Japanese researchers have successfully developed the world's first imaging method for visualising the behaviour of nicotine-adenine dinucleotide derivative (NAD(P)H), a key coenzyme, inside cells. This feat ...

User comments : 0

More news stories

Breakthrough points to new drugs from nature

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

A greener source of polyester—cork trees

On the scale of earth-friendly materials, you'd be hard pressed to find two that are farther apart than polyester (not at all) and cork (very). In an unexpected twist, however, scientists are figuring out ...

Net neutrality balancing act

Researchers in Italy, writing in the International Journal of Technology, Policy and Management have demonstrated that net neutrality benefits content creator and consumers without compromising provider innovation nor pr ...